UBS Group’s M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share MBSC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-500
Closed 11438
2022
Q3
$0 Hold
500
﹤0.01% 11324
2022
Q2
$0 Buy
+500
New +$97 ﹤0.01% 11322

Other funds holding MBSC.WS

UBS Group's MBSC.WS Position: Q4 2022 in Review

UBS Group sold out of M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (MBSC.WS) in Q4 2022, closing a stake of 500 shares.

UBS Group first reported a position in MBSC.WS in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 40 funds tracked by Wall St. Rank hold MBSC.WS as of Q4 2022.

  • UBS Group reported no remaining M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 500 M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q4 2022.
  • UBS Group first reported a position in M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q2 2022 and held it in 2 quarters.
  • UBS Group's M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $0 in Q3 2022.
  • 40 funds tracked by Wall St. Rank held M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.